Back
Amgen 10K Form
Buy
59
AMGN
Amgen
Last Price:
256.69
Seasonality Move:
3.99%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2021-04-28 | 10Q | AMGN/Amgen Quarterly |
| 2021-02-09 | 10K | AMGN/Amgen Annual |
| 2020-10-29 | 10Q | AMGN/Amgen Quarterly |
| 2020-07-29 | 10Q | AMGN/Amgen Quarterly |
| 2020-05-01 | 10Q | AMGN/Amgen Quarterly |
| 2020-02-13 | 10K | AMGN/Amgen Annual |
Receive AMGN News And Ratings
See the #1 stock for the next 7 days that we like better than AMGN
AMGN Financial Statistics
Sales & Book Value
| Annual Sales: | $26.32B |
|---|---|
| Cash Flow: | $3.84B |
| Price / Cash Flow: | 14.25 |
| Annual Sales: | $12.68 |
| Price / Book: | 20.25 |
Profitability
| EPS (TTM): | 14.83000 |
|---|---|
| Net Income (TTM): | $7.98B |
| Gross Margin: | $19.92B |
| Return on Equity: | 182.49% |
| Return on Assets: | 10.87% |
Amgen Earnings Forecast
Key Amgen Financial Ratios
- The Gross Profit Margin over the past 39 years for AMGN is 75.66%.
- The Selling, General & Administrative Expenses for AMGN have been equal to 20.57% of Gross Profit Margin.
- The Research & Development expenses have been 16.84% of Revenue.
- The Interest Expense is 21.46% of Operating Income.
- The Net Earning history of AMGN is 24.89% of Total Revenues.
- Per Share Earnings over the last 39 years have been positive in 25 years.
Amgen Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Drug Manufacturers - General |
| Sector: | Healthcare |
| Current Symbol: | AMGN |
| CUSIP: | 031162 |
| Website: | amgen.com |
Debt
| Debt-to-Equity Ratio: | 9.08 |
|---|---|
| Current Ratio: | 2.77 |
| Quick Ratio: | 2.34 |
Price-to-Earnings
| Trailing P/E Ratio: | 21.2 |
|---|---|
| Forward P/E Ratio: | 12.66 |